RNS Number : 9995O
ValiRx PLC
03 June 2015
3 June 2015
ValiRx Plc
('ValiRx' or the 'Company')
Change of Adviser
London, UK, 3 June 2015 - ValiRx Plc (AIM: VAL), a life science company with a focus on cancer therapeutics and diagnostics for personalised medicine, announces that Northland Capital Partners Limited has been appointed sole broker to the Company with immediate effect.
|
ValiRx Plc |
Tel: +44 (0)20 3008 4416 |
|
Dr Satu Vainikka |
|
|
Cairn Financial Advisers LLP (Nominated Adviser) |
Tel: +44 (0)20 7148 7900 |
|
Liam Murray / Avi Robinson |
|
|
Northland Capital Partners Limited (Broker) |
Tel: +44 (0)20 7382 1100 |
|
Patrick Claridge / John Howes / Abigail Wayne |
|
|
Peckwater PR |
Tel: +44 (0)7879 458 364 |
|
Tarquin Edwards |
This information is provided by RNS
The company news service from the London Stock Exchange